Singapore, March 27 -- Docquity, Southeast Asia's largest network of healthcare professionals (HCPs), and global healthcare company Novartis, haveannounced a multi-year partnership in Malaysia to address the rise of retinal health challenges, such as diabetic macular edema (DME) and age-related macular degeneration (AMD).

The growing prevalence of diabetes in the country, currently estimated at 20% or one in five of the adult population, is associated with the increased incidence of DME.

Harnessing Docquity's insights-driven, omnichannel commercial capabilities under its Awareness to Advocacy (A2A) Programme, Novartis enhances retinal health education for thousands of ophthalmologists and medical retina doctors across the country, while...